82% of Global LPs to Increase Exposure to Private Credit in Next Three Years, CSC Research Finds
23.9.2025 15:00:00 CEST | Business Wire | Press release
Portfolio diversification (76%) tops LP motivations to increase allocations, more than double those citing attractive returns (36%). Private credit GPs anticipate continued AUM growth, led by senior debt and asset-backed finance; cross-border lending set to surge.
More than four fifths (82%) of limited partners (LPs) say they expect to increase allocations to private credit over the next three years, according to a new international study by CSC, the leading provider of global business administration and compliance solutions. Of these LPs, around two fifths (42%) expect “significant” growth in private credit exposure, underscoring the momentum and positive investor sentiment towards the asset class.
The research that canvassed the views of 300 general partners (GPs) and 200 limited partners (LPs) in Europe, Asia Pacific, and North America, found that portfolio diversification was the primary motive behind greater allocation (according to 76% of LPs), ahead of attractive returns (36%).
Private credit GPs are also bullish. The study, commissioned by CSC to inform its new report, “Private Credit 2025: Scaling Global Strategies Through Operational Excellence,” found three fifths (59%) of GPs forecasting AUM growth of 6–10% over a three-year horizon and 31% expecting growth above 10%.
“Private credit has exploded into the mainstream, becoming a truly global, multijurisdictional phenomenon that looks set to attract more and more investor capital,” said Marshall Saffer, managing director, Funds and Capital Markets at CSC. “As a business, we’re seeing first-hand how private credit has evolved, including innovation in structuring and cross-border strategies, and we’re well positioned to help GPs capitalize on strong demand.”
Growth driven by strategy shifts and cross-border expansion
CSC’s study found senior debt and asset-backed finance emerging as the most attractive underlying strategies, with distressed debt ranked lowest in expected growth. Cross-border lending is another major growth area, with 79% of GPs expecting international activity to increase significantly.
However, as the private credit sector grows, administrative complexity is increasingly taking its toll, especially for cross-border strategies where reporting, risk transparency, and operational readiness are under greater scrutiny.
“Private credit’s fast growth presents implicit challenges to operating models for fund managers, and imposes considerable demands on them and other stakeholders, particularly when investing in multiple jurisdictions and across borders,” said Constantinos Kleanthous, managing director, APAC at CSC. “As our study found, GPs have voted with their feet when it comes to outsourcing operational support to dedicated third-party specialists—and even more for functions like loan agency.”
CSC’s report found that 91% of LPs believe GPs who outsource to specialist service providers deliver enhanced reporting. Respondents cited SPV administration, collateral management, and loan agency as crucial in managing fund complexity and enhancing transparency.
As private credit cements its place in global portfolios, the research makes clear that growth must be matched with operational strength. GPs with the right infrastructure, and the right specialist partners will be best placed to seize the opportunity ahead.
For a full copy of “Private Credit 2025: Scaling Global Strategies Through Operational Excellence,” download it at cscglobal.com/service/campaigns/private-credit-2025.
About CSC
CSC is the trusted partner of choice for more than 90% of the Fortune 500®, more than 90% of the 100 Best Global Brands (Interbrand®), and more than 70% of the PEI 300. We are the world’s leading provider of global business administration and compliance solutions, specialized administration services to alternative asset managers across a range of fund strategies, transactions involving capital markets participants in both public and private markets, domain name system management and digital brand and fraud protection, and corporate tax software solutions. Founded in 1899 and headquartered in Wilmington, Delaware, USA, CSC prides itself on being privately held and professionally managed for more than 125 years. CSC has office locations and capabilities in more than 140 jurisdictions across Europe, the Americas, Asia Pacific, and the Middle East. We are a global company capable of doing business wherever our clients are—and we accomplish that by employing experts in every business we serve. We are the business behind business®. Learn more at cscglobal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250923262106/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Iconic Landmark Danjiang Bridge Opened to Redefine Taiwan18.5.2026 12:02:00 CEST | Press release
The Danjiang Bridge, one of Taiwan’s most significant recent public infrastructure projects, officially opened with a series of large-scale public events, transforming the bridge into a new cultural landmark and civic space. The program featured the “Danjiang Bridge Together Arts Festival,” immersive public activities, and a special performance of Light Chain by Cloud Gate Dance Theatre, symbolizing the integration of architecture, engineering, and the arts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260517667930/en/ The Danjiang Bridge is an iconic landmark in Taiwan with global recognition. (Photo via Highway Bureau , Motc) Spanning the mouth of the Tamsui River, the bridge serves as both a major transportation project and a recognizable architectural landmark, establishing a new urban symbol for Taiwan. Designed by Zaha Hadid Architects, the project gained international attention throughout its development and was sel
Arboris Capital Selects ROYC to Expand Private Markets Capabilities on CapGain Platform18.5.2026 09:00:00 CEST | Press release
Arboris Capital Limited (“Arboris”), a DIFC-based firm arranging alternative investments, authorised by the Dubai Financial Services Authority (DFSA), today announced that it has selected ROYC AB (“ROYC”), a private markets technology and infrastructure provider, to support the continued development of its private markets offering through its platform, CapGain. In its ongoing efforts to expand its private markets capabilities across the Middle East, Arboris has undertaken a strategic review of how to further scale its offering while maintaining the integrity of its existing platform. As a result, Arboris has chosen to integrate ROYC’s fund access, sourcing, and structuring capabilities into CapGain, complementing its existing infrastructure. CapGain is Arboris’s proprietary investment platform, purpose-built to facilitate access between international private market opportunities and Professional Investors in the region. CapGain provides fully digital investor onboarding and KYC, a secu
OdysseyRe Announces New Co-Chief Underwriting Officers for EMEA18.5.2026 09:00:00 CEST | Press release
Odyssey Reinsurance Company (OdysseyRe) today announced the appointments of Tegwen Gromellon and Anne-Claire Serres as co-chief underwriting officers of its EMEA division, effective July 1. They succeed longtime Chief Underwriting Officer, Gaël Le Païh, who is retiring later this year following 36 years with the Company. Based in Paris, Serres joined OdysseyRe in 2018 as the market director for France and will lead the division’s business across France, Africa and the Middle East. Gromellon, who joined OdysseyRe in 2004, has served as market director for Germany, Austria, Benelux and Switzerland since 2019. He will take the lead for the rest of Europe, including the relationship with the Company’s representative office in Stockholm for the Nordic markets and across Turkey. “We are delighted to appoint both Tegwen and Anne-Claire to these important leadership positions,” said Isabelle Dubots-Lafitte, chief executive officer of EMEA for OdysseyRe. “These appointments recognize their sign
LogicMonitor and Deutsche Telekom Expand Partnership Across Europe18.5.2026 09:00:00 CEST | Press release
Expanded availability of LogicMonitor within Deutsche Telekom’s managed services portfolio follows successful operational use in the UKSelect outcomes include reduced reporting times and proactive incident preventionExpansion extends across DACH, Benelux, and the Nordics LogicMonitor®, the AI-first platform for Autonomous IT, today announced the expanded availability of its platform within Deutsche Telekom’s managed services portfolio across selected European markets, including DACH, Benelux, and the Nordics. The expansion builds on operational use of LogicMonitor in the United Kingdom since 2023, where it has supported Deutsche Telekom’s service teams in improving visibility across network, cloud, and hybrid infrastructure environments. Experience gained from these deployments is now informing broader service enablement across additional European markets. As enterprise IT environments grow more complex, organisations require more than visibility—they need predictive resilience. Throug
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy18.5.2026 09:00:00 CEST | Press release
ZH9 is very well tolerated with a favourable safety profile, and no dose-limiting toxicities or Grade ≥3 drug-related adverse events reported.ZH9 demonstrates 91% freedom-from-relapse in NMIBC patients who have reached study end.Company plans to run a larger phase 2 study across a range of patient populations spanning intermediate risk and high risk including CIS. Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These data demonstrate ZH9 as a universally applicable treatment for patients. As the treatment is very well tolerated and is showing impactful outcomes for early a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom